Pharmaceutical News

RSS

EETs promote primary tumor growth and metastasis in mouse models of cancer

Drugs that enhance levels of small molecules derived naturally in the body from a major component of animal fats (small molecules known as epoxyeicosatrienoic acids [EETs]) are currently in clinical trials for the treatment of high blood pressure and diabetes.

20 Dec 2011

Routine criminal prosecutions for HIV nondisclosure should be abolished, say experts

Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ.

20 Dec 2011

Weight loss pill without major side effects coming soon

Scientists are on their way to develop a perfect diet pill. The drug, which switches off appetite using hormones that are created naturally in the stomach when it is full, could be the first to be effective in weight loss without side effects.

19 Dec 2011

Yissum introduces novel technology for manufacturing an anti-malaria drug in tobacco

Combating malaria is one of the eight Millennium Development Goals described in the United Nations Millennium Declaration signed by all UN members at the year 2000. A key intervention to control malaria is prompt and effective treatment with artemisinin-based combination therapies.

19 Dec 2011

Bloomberg TV to air segment on Antigen Express' immunotherapeutic breast cancer vaccine

Generex Biotechnology Corporation today announced that Bloomberg Television is scheduled to air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc.

19 Dec 2011

EMA CHMP recommends approval for BioMarin's Novato manufacturing facility expansion

BioMarin Pharmaceutical Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval for the company's manufacturing facility expansion in Novato, CA.

19 Dec 2011

Fluoride supplements not found to be safe or effective

According to the Cochrane Oral Health Group, fluoride supplements fail to reduce tooth decay in primary teeth, permanent teeth cavity-reduction is dubious and health risks are little studied.

19 Dec 2011

HA fillers will see highest growth among facial injectable products in 2013 rebound

According to Millennium Research Group, the global authority on medical technology market intelligence, poor economic conditions will limit growth of the European facial injectables market in 2011 and 2012 down to 2.5 percent per year, but the market will rebound strongly in 2013 and onward, reaching a rate of nearly 12 percent by 2016, for a total market of $420 million.

19 Dec 2011

Affordable artemisinin using tobacco plants

19 Dec 2011

arGEN-X to advance SIMPLE Antibody platform for treatment of autoimmune disorders

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announced today it has received a grant of €1.3 million to further advance its powerful discovery platform for addressing challenging disease targets.

19 Dec 2011

Baxter receives FDA approval for ADVATE to prevent hemophilia A

Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ADVATE [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.

From Baxter International Inc. 17 Dec 2011

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Pfizer Inc. today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company's commitment to help protect millions of infants and young children in the developing world from pneumococcal disease - the leading cause of vaccine-preventable death in young children.

17 Dec 2011

Research reveals role of government funding in pharmaceutical R&D

Research conducted by Columbia Business School Professor Frank Lichtenberg, Courtney C. Brown Professor of Business, Finance and Economics, Healthcare and Pharmaceutical Management Program, and Bhaven Sampat, Assistant Professor in the Department of Health Policy and Management at the Mailman School of Public Health of Columbia University, identifies the respective contributions of direct and indirect government support in research and development of new pharmaceutical drugs.

16 Dec 2011

First reliable method to predict whether SSRIs work on depressed patients

Loyola University Medical Center researchers are reporting what could become the first reliable method to predict whether an antidepressant will work on a depressed patient.

16 Dec 2011

Drugmakers get more time to record gifts to doctors

U.S. drugmakers and device companies got an extension on the deadline to record all payments and gifts to doctors because of a delay in a proposed rule from health officials.

16 Dec 2011

Vaginal progesterone decreases odds of premature delivery in women

A new study co-authored by the University of Kentucky's Dr. John O'Brien found that applying vaginal progesterone to women who are at a high risk of preterm birth significantly decreased the odds of a premature delivery.

16 Dec 2011

Major metropolitan areas show variation in rates of drug-related ED visits

Major metropolitan areas show significant variation in the rates of emergency department (ED) visits involving illicit drugs.

16 Dec 2011

Glucocorticoid inhalation during pregnancy does not increase risk of diseases in offspring

Inhaled glucocorticoids for the treatment of asthma during pregnancy are not associated with an increased risk of most diseases in offspring, but may be a risk factor for endocrine and metabolic disturbances, according to a new study.

16 Dec 2011

Almost two-thirds of pregnant women in B.C. consume prescription drugs

Almost two-thirds of women in British Columbia filled at least one prescription at some point in their pregnancy, including drugs with potential risks, according to a new study by University of British Columbia researchers.

16 Dec 2011

IQWiG publishes report on Esbriet benefit assessment for treatment of IPF

InterMune, Inc. today reported that the private Institute for Quality and Efficiency in Health Care (IQWiG) has today published its report on the benefit assessment of Esbriet (pirfenidone) for the treatment of mild to moderate idiopathic pulmonary fibrosis.

16 Dec 2011

Pharmaceutical News

EETs promote primary tumor growth and metastasis in mouse models of cancer

Routine criminal prosecutions for HIV nondisclosure should be abolished, say experts

Weight loss pill without major side effects coming soon

Yissum introduces novel technology for manufacturing an anti-malaria drug in tobacco

Bloomberg TV to air segment on Antigen Express' immunotherapeutic breast cancer vaccine

EMA CHMP recommends approval for BioMarin's Novato manufacturing facility expansion

Fluoride supplements not found to be safe or effective

HA fillers will see highest growth among facial injectable products in 2013 rebound

Affordable artemisinin using tobacco plants

arGEN-X to advance SIMPLE Antibody platform for treatment of autoimmune disorders

Baxter receives FDA approval for ADVATE to prevent hemophilia A

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Research reveals role of government funding in pharmaceutical R&D

First reliable method to predict whether SSRIs work on depressed patients

Drugmakers get more time to record gifts to doctors

Vaginal progesterone decreases odds of premature delivery in women

Major metropolitan areas show variation in rates of drug-related ED visits

Glucocorticoid inhalation during pregnancy does not increase risk of diseases in offspring

Almost two-thirds of pregnant women in B.C. consume prescription drugs

IQWiG publishes report on Esbriet benefit assessment for treatment of IPF

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News